# Biological Variation Modeling Report
## Retinal Prosthesis Patient Variability Analysis

## Executive Summary
This analysis demonstrates significant patient-to-patient variability in retinal prosthetic vision 
due to biological differences in retinal tissue properties. Key findings:

- **Threshold Variability**: 1.4μA to 1.4μA (1.0x range)
- **Best Spatial Resolution**: Young Patient (Good Retinal Health)
- **Poorest Spatial Resolution**: Young Patient (Good Retinal Health)

## Patient Profile Analysis

### Young Patient (Good Retinal Health)
- **Description**: Younger patient with well-preserved retinal structure
- **Spatial Decay (ρ)**: 200μm
- **Axonal Decay (λ)**: 600μm

### Typical Patient (Moderate Degeneration)
- **Description**: Average patient with moderate retinal degeneration
- **Spatial Decay (ρ)**: 300μm
- **Axonal Decay (λ)**: 400μm

### Advanced Degeneration Patient
- **Description**: Patient with advanced retinal degeneration
- **Spatial Decay (ρ)**: 500μm
- **Axonal Decay (λ)**: 200μm

### Elderly Patient (Age-Related Changes)
- **Description**: Elderly patient with age-related retinal changes
- **Spatial Decay (ρ)**: 400μm
- **Axonal Decay (λ)**: 300μm

### Focal Preservation Patient
- **Description**: Patient with focal areas of preserved retinal function
- **Spatial Decay (ρ)**: 150μm
- **Axonal Decay (λ)**: 800μm

## Clinical Implications
1. **Personalized Programming**: Each patient requires individual device optimization
2. **Threshold Testing**: Comprehensive threshold mapping is essential
3. **Outcome Prediction**: Biological parameters can predict visual outcomes
4. **Treatment Planning**: Patient selection and counseling should consider biological factors